Treatment of Metastatic Biliary Cancers With Irinotecan and 5-Fluorouracil Based Chemotherapy After Platinum/Gemcitabine Progression: A Systematic Review and Meta-Analysis
-
Published:2024-06
Issue:
Volume:
Page:
-
ISSN:1533-0028
-
Container-title:Clinical Colorectal Cancer
-
language:en
-
Short-container-title:Clinical Colorectal Cancer
Author:
Voutsadakis Ioannis A.ORCID,
Kokkali Stefania,
Digklia Antonia
Reference36 articles.
1. Cancer statistics, 2024;Siegel;CA Cancer J Clin,2024
2. Biliary tract cancer: epidemiology, radiotherapy, and molecular profiling;Bridgewater;Am Soc Clin Oncol Educ Book,2016
3. Optimizing patient pathways in advanced biliary tract cancers: recent advances and a french perspective;Neuzillet;Target Oncol,2023
4. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer;Oh;NEJM Evid,2022
5. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial